JNJ-66525433

· Janssen Research & Development, LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for JNJ-66525433, covering 2025-02-03 to 2025-02-03. Get the full timeline:

Most recent: Clinical Trial Update: A Study of JNJ-66525433 in Healthy Participants and Participants With Ulcerative Colitis [Phase 1]